Embed

Academic

Authors

Michelle Tubiana-Hulin

Michelle Tubiana-Hulin,Oncology,Anatomy,Molecular Biology

Edit

Michelle Tubiana-Hulin

Publications: 22 | Citations: 244

Fields: Oncology, Anatomy, Molecular Biology

Collaborated with 73 co-authors from 1989 to 2009 | Cited by 1112 authors

Cumulative Annual

Sort by:

Publications (22)

BibTeX | RIS | RefWorks Download

Breast Cancer With Synchronous Metastases: Survival Impact of Exclusive Locoregional Radiotherapy (Citations: 11)

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=30827137&selfId1=54183237&selfId2=0&maxNumber=12&query=

Journal: Journal of Clinical Oncology - J CLIN ONCOL , vol. 27, no. 9, pp. 1375-1381, 2009

Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902 (Citations: 5)

, , , , , ,

Journal: Breast Cancer Research and Treatment - BREAST CANCER RES TREAT , vol. 115, no. 1, pp. 101-113, 2009

Éditorial

Journal: Oncologie , vol. 11, no. 1, pp. 1-1, 2009

Oligonucleotide microarray analysis of estrogen receptor -positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen (Citations: 1)

, , , , , , , , , , ,

Journal: Journal of Molecular Endocrinology - J MOLECULAR ENDOCRINOL , vol. 39, no. 4, pp. 305-318, 2007

Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution (Citations: 42)

Journal: Annals of Oncology - ANN ONCOL , vol. 17, no. 8, pp. 1228-1233, 2006

Sort by:

Citations (244 times by 233 publications)

Impact of Progression During Neoadjuvant Chemotherapy on Surgical Management of Breast Cancer (Citations: 1)

, , , , , , ,

Journal: Annals of Surgical Oncology - ANNALS SURG ONCOLOGY , vol. 18, no. 4, pp. 932-938, 2011

MIB1/Ki67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups (Citations: 1)

, , , , ,

Journal: Breast Cancer Research and Treatment - BREAST CANCER RES TREAT , vol. 127, no. 3, pp. 591-599, 2011

Genomic Grade Index: An important tool for assessing breast cancer tumor grade and prognosis (Citations: 1)

, ,

Journal: Critical Reviews in Oncology Hematology - CRIT REV ONCOL HEMATOL , vol. 77, no. 1, pp. 20-29, 2011

Neoadjuvant endocrine therapy of breast cancer: which patients would benefit and what are the advantages?

, , , , , , , , , ,

Journal: Breast Cancer , vol. 18, no. 2, pp. 85-91, 2011

Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patients

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=48832340&selfId1=54183237&selfId2=0&maxNumber=12&query=

Journal: Breast Cancer Research and Treatment - BREAST CANCER RES TREAT , vol. 128, no. 2, pp. 429-435, 2011

Comments

Co-authors (73)

Journals (13)

Keywords (47)

Michelle Tubiana-Hulin,Oncology,Anatomy,Molecular Biology

Publications (22)

BibTeX | RIS | RefWorks Download

Breast Cancer With Synchronous Metastases: Survival Impact of Exclusive Locoregional Radiotherapy (Citations: 11)

Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902 (Citations: 5)

Éditorial

Oligonucleotide microarray analysis of estrogen receptor -positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen (Citations: 1)

Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution (Citations: 42)

Citations (244 times by 233 publications)

Impact of Progression During Neoadjuvant Chemotherapy on Surgical Management of Breast Cancer (Citations: 1)

MIB1/Ki67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups (Citations: 1)

Genomic Grade Index: An important tool for assessing breast cancer tumor grade and prognosis (Citations: 1)

Neoadjuvant endocrine therapy of breast cancer: which patients would benefit and what are the advantages?

Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patients


	View FAQ about top research areas and Fields of study

Co-authors (73)

Journals (13)

Keywords (47)

Michelle Tubiana-Hulin,Oncology,Anatomy,Molecular Biology

Publications (22) BibTeX | RIS | RefWorks Download

Breast Cancer With Synchronous Metastases: Survival Impact of Exclusive Locoregional Radiotherapy (Citations: 11)

Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902 (Citations: 5)

Éditorial

Oligonucleotide microarray analysis of estrogen receptor -positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen (Citations: 1)

Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution (Citations: 42)

Citations (244 times by 233 publications)

Impact of Progression During Neoadjuvant Chemotherapy on Surgical Management of Breast Cancer (Citations: 1)

MIB1/Ki67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups (Citations: 1)

Genomic Grade Index: An important tool for assessing breast cancer tumor grade and prognosis (Citations: 1)

Neoadjuvant endocrine therapy of breast cancer: which patients would benefit and what are the advantages?

Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patients

Publications (22)

BibTeX | RIS | RefWorks Download